Protalix BioTherapeutics Inc (AMEX:PLX)
$ 1.1 -0.15 (-12%) Market Cap: 80.65 Mil Enterprise Value: 62.37 Mil PE Ratio: 55.00 PB Ratio: 2.39 GF Score: 58/100

Q1 2019 Protalix Biotherapeutics Inc Earnings Call Transcript

May 06, 2019 / 12:30PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Protalix First Quarter 2019 Financial Results and Corporate Conference Call. (Operator Instructions) As a reminder, this call will be recorded.

I would now like to introduce your host for today's conference, Yossi Maimon. Please go ahead.

Yossi Maimon
Protalix BioTherapeutics, Inc. - CFO, VP, Treasurer & Secretary

Thank you. Hello, everybody. Good morning. Welcome to Protalix BioTherapeutics 2019 First Quarter Earnings Result and Corporate Update Conference Call.

With me today is Moshe Manor, our President and CEO. A press release announcing the result is available on our website. I'd just like to take a moment -- ask you to take a moment and read the disclaimer about the forward-looking statements in the press release. The earning release and this teleconference includes some forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot